Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cell therapies for liver diseases.

Literature DB >> 22140063

Cell therapies for liver diseases.

Yue Yu¹, James E Fisher, Joseph B Lillegard, Brian Rodysill, Bruce Amiot, Scott L Nyberg.

Abstract

Cell therapies, which include bioartificial liver support and hepatocyte transplantation, have emerged as potential treatments for a variety of liver diseases. Acute liver failure, acute-on-chronic liver failure, and inherited metabolic liver diseases are examples of liver diseases that have been successfully treated with cell therapies at centers around the world. Cell therapies also have the potential to be widely applied to other liver diseases, including noninherited liver diseases and liver cancer, and to improve the success of liver transplantation. Here we briefly summarize current concepts of cell therapy for liver diseases.

Entities: CellLine Chemical Disease Gene Species

Mesh：

Year: 2012 PMID： 22140063 PMCID： PMC3245367 DOI： 10.1002/lt.22467

Source DB: PubMed Journal: Liver Transpl ISSN： 1527-6465 Impact factor: 5.799

96 in total

1. Rapid, large-scale formation of porcine hepatocyte spheroids in a novel spheroid reservoir bioartificial liver.

Authors: Scott L Nyberg; Joseph Hardin; Bruce Amiot; Upendra A Argikar; Rory P Remmel; Piero Rinaldo
Journal: Liver Transpl Date: 2005-08 Impact factor: 5.799

2. New alternatives to the treatment of acute liver failure.

Authors: E Pareja; M Cortes; A Bonora; P Fuset; F Orbis; R Lopez; J Mir
Journal: Transplant Proc Date: 2010-10 Impact factor: 1.066

3. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure.

Authors: A J Ellis; R D Hughes; J A Wendon; J Dunne; P G Langley; J H Kelly; G T Gislason; N L Sussman; R Williams
Journal: Hepatology Date: 1996-12 Impact factor: 17.425

Review 4. Immunomodulatory properties and therapeutic application of mesenchymal stem cells.

Authors: M Shi; Z-W Liu; F-S Wang
Journal: Clin Exp Immunol Date: 2011-02-24 Impact factor: 4.330

5. Caspase inhibition reduces apoptotic death of cryopreserved porcine hepatocytes.

Authors: T Yagi; J A Hardin; Y M Valenzuela; H Miyoshi; G J Gores; S L Nyberg
Journal: Hepatology Date: 2001-06 Impact factor: 17.425

6. Adipose tissue-derived mesenchymal stem cell-based liver gene delivery.

Authors: Hong Li; Bin Zhang; Yuanqing Lu; Marda Jorgensen; Bryon Petersen; Sihong Song
Journal: J Hepatol Date: 2010-11-03 Impact factor: 25.083

7. Human umbilical cord blood-derived mesenchymal stem cells improve glucose homeostasis in rats with liver cirrhosis.

Authors: Kyung Hee Jung; Yun-Kyung Uhm; Yun Jeong Lim; Sung-Vin Yim
Journal: Int J Oncol Date: 2011-04-28 Impact factor: 5.650

Review 8. Artificial and bioartificial liver support.

Authors: Travis J McKenzie; Joseph B Lillegard; Scott L Nyberg
Journal: Semin Liver Dis Date: 2008-05 Impact factor: 6.115

Review 9. Generation and regeneration of cells of the liver and pancreas.

Authors: Kenneth S Zaret; Markus Grompe
Journal: Science Date: 2008-12-05 Impact factor: 47.728

10. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure.

Authors: Biju Parekkadan; Daan van Poll; Kazuhiro Suganuma; Edward A Carter; François Berthiaume; Arno W Tilles; Martin L Yarmush
Journal: PLoS One Date: 2007-09-26 Impact factor: 3.240

39 in total

Review 1. Human-relevant preclinical in vitro models for studying hepatobiliary development and liver diseases using induced pluripotent stem cells.

Authors: Pooja Chaudhari; Lipeng Tian; Zhaohui Ye; Yoon-Young Jang
Journal: Exp Biol Med (Maywood) Date: 2019-02-26

Review 2. Vascularized microfluidic organ-chips for drug screening, disease models and tissue engineering.

Authors: Tatsuya Osaki; Vivek Sivathanu; Roger D Kamm
Journal: Curr Opin Biotechnol Date: 2018-04-12 Impact factor: 9.740

Review 3. Proceedings: moving toward cell-based therapies for liver disease.

Authors: Lisa C Kadyk; Lila R Collins; Neil J Littman; Maria T Millan
Journal: Stem Cells Transl Med Date: 2015-01-30 Impact factor: 6.940

4. Pivotal preclinical trial of the spheroid reservoir bioartificial liver.

Authors: Jaime M Glorioso; Shennen A Mao; Brian Rodysill; Taufic Mounajjed; Walter K Kremers; Faysal Elgilani; Raymond D Hickey; Hakon Haugaa; Christopher F Rose; Bruce Amiot; Scott L Nyberg
Journal: J Hepatol Date: 2015-03-25 Impact factor: 25.083

5. Implications of differential stress response activation following non-frozen hepatocellular storage.

Authors: William L Corwin; John M Baust; John G Baust; Robert G Van Buskirk
Journal: Biopreserv Biobank Date: 2013-02 Impact factor: 2.300

Review 6. Immunological aspects of liver cell transplantation.

Authors: Felix Oldhafer; Michael Bock; Christine S Falk; Florian W R Vondran
Journal: World J Transplant Date: 2016-03-24

Review 7. Cellular therapy for liver disease.

Authors: Robert C Huebert; Jorge Rakela
Journal: Mayo Clin Proc Date: 2014-03 Impact factor: 7.616

8. Noninvasive 3-dimensional imaging of liver regeneration in a mouse model of hereditary tyrosinemia type 1 using the sodium iodide symporter gene.

Authors: Raymond D Hickey; Shennen A Mao; Bruce Amiot; Lukkana Suksanpaisan; Amber Miller; Rebecca Nace; Jaime Glorioso; Michael K O'Connor; Kah Whye Peng; Yasuhiro Ikeda; Stephen J Russell; Scott L Nyberg
Journal: Liver Transpl Date: 2015-03-12 Impact factor: 5.799

Review 9. New and old technologies for organ replacement.

Authors: Jeffrey L Platt; Marilia Cascalho
Journal: Curr Opin Organ Transplant Date: 2013-04 Impact factor: 2.640

10. MicroRNA Regulates Hepatocytic Differentiation of Progenitor Cells by Targeting YAP1.

Authors: Kwang Hwa Jung; Ryan L McCarthy; Chong Zhou; Nadima Uprety; Michelle Craig Barton; Laura Beretta
Journal: Stem Cells Date: 2016-02-01 Impact factor: 6.277